Search Results - Markus Ponleitner

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    High erythropoietin levels are associated with low neurofilament light levels in simulated high altitude: a further hint for neuroprotection by erythropoietin by Klaus Berek, Anna Berek, Angelika Bauer, Angelika Bauer, Dagmar Rudzki, Franziska Di Pauli, Gabriel Bsteh, Gabriel Bsteh, Markus Ponleitner, Markus Ponleitner, Benedikt Treml, Axel Kleinsasser, Thomas Berger, Thomas Berger, Maria Wille, Martin Burtscher, Markus Reindl, Florian Deisenhammer, Harald Hegen

    Published in Frontiers in Neurology (2025-07-01)
    Get full text
    Article


  2. 2

    Pregnancy outcomes of Fabry disease in Austria (PROFABIA)-a retrospective cohort-study by Natalja Haninger-Vacariu, Kyra Anastopoulos, Christof Aigner, Raute Sunder-Plassmann, Constantin Gatterer, Markus Ponleitner, Gere Sunder-Plassmann, Alice Schmidt

    Published in Orphanet Journal of Rare Diseases (2024-04-01)
    Get full text
    Article


  3. 3

    Investigation of serum neurofilament light chain as a biomarker in Fabry disease by Markus Ponleitner, Constantin Gatterer, Gabriel Bsteh, Jakob Rath, Patrick Altmann, Thomas Berger, Senta Graf, Gere Sunder-Plassmann, Paulus Stefan Rommer

    Published in Scientific Reports (2024-10-01)
    Get full text
    Article


  4. 4

    The presence of oligoclonal bands predicts conversion to multiple sclerosis in isolated myelitis by Tobias Monschein, Markus Ponleitner, Gabriel Bsteh, Nik Krajnc, Gudrun Zulehner, Paulus Rommer, Barbara Kornek, Thomas Berger, Fritz Leutmezer, Tobias Zrzavy

    Published in Scientific Reports (2024-10-01)
    Get full text
    Article


  5. 5

    Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial by Patrick Altmann, Markus Ponleitner, Tobias Monschein, Nik Krajnc, Gudrun Zulehner, Tobias Zrzavy, Fritz Leutmezer, Paulus Stefan Rommer, Barbara Kornek, Thomas Berger, Gabriel Bsteh

    Published in Digital Health (2022-11-01)
    Get full text
    Article


  6. 6

    Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis by Patrick Altmann, Fritz Leutmezer, Katharina Leithner, Tobias Monschein, Markus Ponleitner, Miranda Stattmann, Paulus Stefan Rommer, Tobias Zrzavy, Gudrun Zulehner, Klaus Berek, Thomas Berger, Gabriel Bsteh

    Published in Frontiers in Neurology (2021-02-01)
    Get full text
    Article


  7. 7

    Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders by Andrea Villoria-González, Bettina Zierfuss, Patricia Parzer, Elisabeth Heuböck, Violetta Zujovic, Petra Waidhofer-Söllner, Markus Ponleitner, Paulus Rommer, Jens Göpfert, Sonja Forss-Petter, Johannes Berger, Isabelle Weinhofer

    Published in Biomolecules (2023-11-01)
    Get full text
    Article


  8. 8

    Neurofilament Light Chain Is Associated With Acute Mountain Sickness by Klaus Berek, Anna Lindner, Franziska Di Pauli, Gabriel Bsteh, Benedikt Treml, Markus Ponleitner, Clemens Engler, Axel Kleinsasser, Thomas Berger, Maria Wille, Martin Burtscher, Florian Deisenhammer, Harald Hegen

    Published in Brain and Behavior (2024-11-01)
    Get full text
    Article


  9. 9

    Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease by Constantin Gatterer, Dietrich Beitzke, Senta Graf, Max Lenz, Gere Sunder-Plassmann, Christopher Mann, Markus Ponleitner, Robert Manka, Daniel Fritschi, Pierre-Alexandre Krayenbuehl, Philipp Kamm, Olivier Dormond, Frédéric Barbey, Pierre Monney, Albina Nowak

    Published in Life (2023-05-01)
    Get full text
    Article


  10. 10

    Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort studyResearch in context by Harald Hegen, Klaus Berek, Gabriel Bsteh, Michael Auer, Patrick Altmann, Franziska Di Pauli, Astrid Grams, Dejan Milosavljevic, Markus Ponleitner, Paulina Poskaite, Christine Schnabl, Sebastian Wurth, Anne Zinganell, Thomas Berger, Janette Walde, Florian Deisenhammer

    Published in EBioMedicine (2023-05-01)
    Get full text
    Article


  11. 11

    Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1381-452-specific antibody titers by Hannes Vietzen, Laura M. Kühner, Sarah M. Berger, Markus Ponleitner, Marianne Graninger, Charlotte Pistorius, Christof Jungbauer, Markus Reindl, Henrieke Saucke, Franziska Kauth, Eva-Maria Wendel, Kevin Rostásy, Markus Breu, Barbara Kornek, Gabriel Bsteh, Thomas Berger, Paulus Rommer, Elisabeth Puchhammer-Stöckl

    Published in Nature Communications (2025-07-01)
    Get full text
    Article


  12. 12

    Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold by Gabriel Bsteh, Harald Hegen, Nik Krajnc, Fabian Föttinger, Patrick Altmann, Michael Auer, Klaus Berek, Barbara Kornek, Fritz Leutmezer, Stefan Macher, Tobias Monschein, Markus Ponleitner, Paulus Rommer, Christiane Schmied, Karin Zebenholzer, Gudrun Zulehner, Tobias Zrzavy, Florian Deisenhammer, Franziska Di Pauli, Berthold Pemp, Thomas Berger

    Get full text
    Article


  13. 13

    Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophyResearch in context by Isabelle Weinhofer, Paulus Rommer, Andreas Gleiss, Markus Ponleitner, Bettina Zierfuss, Petra Waidhofer-Söllner, Stéphane Fourcade, Katharina Grabmeier-Pfistershammer, Marie-Christine Reinert, Jens Göpfert, Anne Heine, Hemmo A.F. Yska, Carlos Casasnovas, Verónica Cantarín, Caroline G. Bergner, Eric Mallack, Sonja Forss-Petter, Patrick Aubourg, Annette Bley, Marc Engelen, Florian Eichler, Troy C. Lund, Aurora Pujol, Wolfgang Köhler, Jörn-Sven Kühl, Johannes Berger

    Published in EBioMedicine (2023-10-01)
    Get full text
    Article


Search Tools: